Stocks and Investing Stocks and Investing
Tue, September 24, 2024

Jonathan Aschoff Maintained (zvra) at Strong Buy with Increased Target to $21 on, Sep 24th, 2024


Published on 2024-10-28 14:26:12 - WOPRAI, Jonathan Aschoff
  Print publication without navigation


Jonathan Aschoff of Roth MKM, Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Increased Target from $19 to $21 on, Sep 24th, 2024.

Jonathan has made no other calls on ZVRA in the last 4 months.



There are 3 other peers that have a rating on ZVRA. Out of the 3 peers that are also analyzing ZVRA, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Jonathan


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $20 on, Friday, September 20th, 2024
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $22 on, Wednesday, September 18th, 2024
  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy on, Wednesday, August 14th, 2024
Contributing Sources